Drug recall
Glyburide Tablets, USP, 2.5 mg, 1000 count bottles, Rx only, Manufactured By: Novopharm Limited, Toronto, CAN…
FDA recall event 30492 · Class II · Teva Pharmaceuticals USA
Key facts
| Event ID | 30492 |
|---|---|
| Recall numbers | D-073-5 |
| Recalling firm | Teva Pharmaceuticals USA |
| Product type | Drugs |
| Products | Glyburide Tablets, USP, 2.5 mg, 1000 count bottles, Rx only, Manufactured By: Novopharm Limited, Toronto, CAN M1B 2K9, Manufactured for TEVA Pharmaceuticals, Sellersville, PA 18960 ***** NDC… |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Presence of foreign tablet (Hydrochlorothiazide 25 mg) |
| Initiation date | Nov 22, 2004 |
| City | North Wales |
| Country | United States |
| FEI number | 3003092769 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports